Previous 10 | Next 10 |
AerSale (NASDAQ:ASLE) -36% on Q3 earnings release. Purple Innovation (NASDAQ:PRPL) -32% on Q3 earnings release. Poshmark (NASDAQ:POSH) -30% on Q3 earnings release. Upstart Holdings (NASDAQ:UPST) -23% on Q3 earnings release. AnPac Bio-Medical S...
Avenue Therapeutics (NASDAQ:ATXI) has prices a $2.6M public offering of common stock at $1.34. In addition, the Company granted the underwriters a 45-day option to purchase additional shares, representing up to 15% of the offering, solely to cover over-allotments. The total gross pr...
NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced the pricing of an underwritten public offering with gross pro...
Remark Holdings (NASDAQ:MARK) +266%. Sonim Technologies (NASDAQ:SONM) +96%. Creatd (NASDAQ:CRTD) +69% announces second NFT drop, includes photographs of former President Donald Trump PAE Incorporated (NASDAQ:PAE) +67% Amentum to buy PAE in an all-cash deal valued at ~$1.9 ...
NEW YORK, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today announced that it has received a written interim response from the Offi...
Avenue Therapeutics Inc. (NASDAQ:ATXI) traded today at a new 52-week low of $1.76. This new low was reached on above average trading volume as 996,000 shares traded hands, while the average 30-day volume is approximately 523,000 shares. In the past 52 weeks, Avenue Therapeutics Inc. shar...
Avenue Therapeutics Inc. (NASDAQ:ATXI) traded at a new 52-week low today of $1.96. So far today approximately 996,000 shares have been exchanged, as compared to an average 30-day volume of 509,000 shares. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and mar...
Avenue Therapeutics Inc. (NASDAQ:ATXI) traded at a new 52-week low today of $2.13. So far today approximately 996,000 shares have been exchanged, as compared to an average 30-day volume of 502,000 shares. Avenue Therapeutics Inc is a specialty pharmaceutical company that develops and mar...
Shares of Avenue Therapeutics Inc. (NASDAQ:ATXI) traded at a new 52-week low today of $2.65. This new low was reached on above average trading volume as 996,000 shares traded hands, while the average 30-day volume is approximately 138,000 shares. Avenue Therapeutics Inc. (NASDAQ:ATXI) ha...
Shares of Avenue Therapeutics Inc. (NASDAQ:ATXI) traded at a new 52-week low today of $2.64. Approximately 996,000 shares have changed hands today, as compared to an average 30-day volume of 138,000 shares. Avenue Therapeutics Inc. has overhead space with shares priced $2.66, or 42.8% be...
News, Short Squeeze, Breakout and More Instantly...
Avenue Therapeutics Inc. Company Name:
ATXI Stock Symbol:
NASDAQ Market:
Avenue Therapeutics Inc. Website:
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced tha...
MIAMI, May 16, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the ...
– Raised a total of $9.4 million in gross proceeds from warrant exercise transactions since January 2024 – MIAMI, May 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutica...